Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 1Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 3Mycosis Fungoides 2Sezary Syndrome 1Parapsoriasis 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myeloid, Acute 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Mycophenolic Acid 7fludarabine phosphate 6Radiotherapy 6Cyclophosphamide 6Antilymphocyte Serum 6Rituximab 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5Cyclosporine 5Whole-Body Irradiation 4Tacrolimus 4Flow Cytometry 4Etoposide 4Cord Blood Stem Cell Transplantation 4Busulfan 4tanespimycin 3Methotrexate 3Melphalan 3Lenalidomide 3Bortezomib 3plerixafor 2nelarabine 2mogamulizumab 2aldesleukin 2Vincristine 2Polymerase Chain Reaction 2Photopheresis 2Moxifloxacin 2Magnetic Resonance Spectroscopy 2Immunosuppression Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sezary Syndrome × Bexarotene × Clear all
NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡